Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical OutcomeMarie‐Christine Alessi, Norbert Nighoghossian, Philippe Grosjean et al.|Cerebrovascular Diseases|2016Cited by 17